INNOVA CAPTAB
|
The Current P/S Ratio of INNOVA CAPTAB is 2.73.
| Share Price | ₹713.3 | Mar 17,2026 |
| Market Cap | ₹4,079.8 Cr | |
| Sales-TTM | ₹1,497.0 Cr | TTM-Consolidated Results |
| Price/Sales | 2.73x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of INNOVA CAPTAB
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,079.8 Cr] as on Mar 17,2026
(/) Sales [ ₹1,497.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.73x ]
Thus, for INNOVA CAPTAB , the investors are currently willing to pay '2.73 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of INNOVA CAPTAB !
The chart below summarizes the trend in P/S Ratio of INNOVA CAPTAB over the last five years.
Historical PS (Price/Sales) ratio chart of INNOVA CAPTAB
PS Ratio Performance Analysis for INNOVA CAPTAB
- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.28x.
- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2025 at 4.04x.
- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does INNOVA CAPTAB 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| INNOVA CAPTAB | 1,497.0 | 2.73 | 4,079.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.58 | 430,825.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.66 | 161,535.0 |
| CIPLA LTD | 28,351.1 | 3.65 | 103,513.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.44 | 145,733.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.09 | 107,094.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.13 | 85,350.2 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.43 | 89,544.8 |
| LUPIN LTD | 26,150.5 | 4.02 | 105,040.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.25 | 74,772.4 |
| ABBOTT INDIA LTD | 6,824.1 | 8.24 | 56,235.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INNOVA CAPTAB 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.25x |
| Max industry PS | 15.66x |
| Median industry PS | 4.02x |
| Average industry PS | 6.20x |
You may also like the below Video Courses